APOE基因型与无痴呆老年人早期β-淀粉样蛋白积累
该研究分析595例无痴呆老年人(Aβ- 325例,Aβ+ 270例)的纵向florbetapir PET数据,发现APOE ε4和较老年龄与基线Aβ+分类风险较高相关;在Aβ-组中,ε4携带者Aβ积累速率显著快于ε3和ε2,较老年龄与更高积累速率相关,而APOE ε2具有保护作用;在Aβ+组中,APOE组间积累速率无显著差异。
要点
- APOE ε4和较老年龄是无痴呆老年人基线Aβ+的预测因素。
- Aβ-组中ε4携带者纵向Aβ积累速率显著快于ε3和ε2携带者。
- Aβ+组中不同APOE基因型的Aβ积累速率无显著差异。
核心结论
- APOE ε4携带和较老年龄是Aβ-组纵向Aβ积累的预测因素,但在Aβ+组中不是。
- APOE ε2携带对Aβ-组纵向Aβ积累具有保护作用。
- APOE基因型结合实际年龄可能有助于选择初级预防试验的参与者,以在Aβ水平异常前阻止积累。
研究设计与样本
- 研究分析了595例无痴呆老年人,横断面分类为Aβ-(n=325)和Aβ+(n=270),使用纵向florbetapir PET。
- 采用线性混合模型检验年龄和APOE基因型对纵向Aβ积累的影响。
主要发现
- APOE ε4和较老年龄与基线Aβ+分类风险较高相关。
- Aβ- ε3年积累率为0.0021 ± 0.0007 SUVR单位,Aβ- ε4为0.0044 ± 0.0010 SUVR单位,均显著大于零。
- Aβ+ ε3年积累率为0.0141 ± 0.0019 SUVR单位,Aβ+ ε4为0.0126 ± 0.0018 SUVR单位,均显著大于零。
- Aβ-组中ε4携带者Aβ积累显著快于ε3和ε2携带者。
- Aβ+组中不同APOE基因型的Aβ积累速率无显著差异;Aβ-组中较老年龄与更高积累速率相关。
临床怎么用
- APOE基因型结合年龄可能有助于识别Aβ积累风险较高的无痴呆老年人,用于初级预防试验的参与者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify associations between APOE ε4 allele and age on longitudinal rates of β-amyloid (Aβ) accumulation within Aβ+ and Aβ- older individuals without dementia. METHODS: We analyzed 595 older adults without dementia classified cross-sectionally as Aβ- (n = 325) and Aβ+ (n = 270) using longitudinal florbetapir PET. The influence of age and APOE genotype on longitudinal accumulation of Aβ was examined with linear mixed models. RESULTS: APOE ε4 and older age were associated with higher risk of being classified as Aβ+ at baseline. The annual rate of Aβ accumulation was significantly greater than zero for Aβ- ε3 (0.0021 ± 0.0007 standardized uptake value ratio [SUVR] units) and Aβ- ε4 (0.0044 ± 0.0010 SUVR units), as well as Aβ+ ε3 (0.0141 ± 0.0019 SUVR units) and Aβ+ ε4 (0.0126 ± 0.0018 SUVR units). Aβ accumulation was significantly faster in Aβ- ε4 compared to Aβ- ε3 and Aβ- ε2. Rates of Aβ accumulation did not differ significantly between Aβ+ APOE groups. Older age was associated with higher rates of Aβ accumulation in the Aβ- group. CONCLUSIONS: APOE ε4 carriage and older age were predictors of longitudinal Aβ accumulation within the Aβ- group but not the Aβ+ group. APOE ε2 carriage was protective against longitudinal Aβ accumulation within the Aβ- group. APOE genotype in conjunction with chronologic age may aid in participant selection for primary prevention trials aimed at halting Aβ accumulation before abnormal levels are reached.
引用
- Lim YY, Mormino EC. APOE genotype and early β-amyloid accumulation in older adults without dementia. Neurology. 2017. PMID: 28794245. doi:10.1212/WNL.0000000000004336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。